FLGT R&D to Revenue
Fulgent Genetics Inc · R&D to Revenue
FLGT R&D to Revenue
Latest reported16.71%period ending
FLGT FY R&D/Revenue (40.77% → 16.71%)
Latest values, visible window
High-resolution chart · PNG
FLGT r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 16.7059% | |
| 17.2209% | |
| 14.3285% | |
| 4.6707% | |
| 2.44% | |
| 2.7459% | |
| 20.0965% | |
| 25.9119% | |
| 22.5467% | |
| 19.4682% | |
| 46.2719% | |
| 40.7668% |